Ipsen Biopharm Ltd. · France / United Kingdom (Ipsen Biopharm); imported via Korean wholesale channel
Dysport 500U is FDA-approved abobotulinumtoxinA manufactured by Ipsen Biopharm Ltd. (France / UK). Each single-use vial contains 500 Dysport-calibrated Speywood Units of botulinum toxin type A (Hall strain) as vacuum-dried powder for reconstitution. Dysport units are calibrated independently — they are NOT interchangeable 1:1 with Allergan Botox, Xeomin, or any Korean botulinum toxin units. The 500U pack is positioned for multi-zone single-patient or multi-patient shared-vial protocols.
This product is vacuum-dried. The vial may appear nearly empty before reconstitution — this is normal product appearance, not a defect. The full dose is present and dissolves into a clear, colourless solution when reconstituted with sterile saline.
Dysport is manufactured by Ipsen Biopharm Ltd. in France/UK. This listing is the Korean-imported wholesale channel version with English labels and KFDA registration — transparent disclosure for buyers who specifically want Korean-channel inventory pricing. The active ingredient abobotulinumtoxinA, manufacturing facility, and product specifications are identical to Dysport sold through other regional channels. Dysport is the only major non-Korean-manufactured botulinum toxin commonly available in the Korean B2B channel.
Why this product is different
Dysport carries FDA approval for cosmetic glabellar lines (2009) and therapeutic indications including cervical dystonia, upper and lower limb spasticity, and pediatric lower limb spasticity. Dysport contains abobotulinumtoxinA, manufactured by Ipsen at facilities in France and the UK. The Dysport manufacturing process produces a different complex protein profile and lighter molecular weight distribution compared to onabotulinumtoxinA (Allergan Botox) or incobotulinumtoxinA (Merz Xeomin). Critically, Dysport units are calibrated independently in Speywood Units and are NOT interchangeable on a 1:1 basis with units of other botulinum toxin products — practitioners switching between products must consult published unit-conversion guidelines.
Mechanism of action
Dysport contains abobotulinumtoxinA, a serotype A botulinum neurotoxin. Mechanism is shared across serotype A products: the toxin’s heavy chain binds to specific receptors on motor nerve terminals; the light chain enters the nerve cytoplasm and cleaves SNAP-25 — a SNARE complex protein required for acetylcholine vesicle fusion at the neuromuscular junction. Acetylcholine release is blocked, the motor nerve cannot signal the muscle to contract, and the targeted muscle relaxes. The Dysport manufacturing process produces a different complex protein profile than onabotulinumtoxinA (Allergan Botox) or incobotulinumtoxinA (Merz Xeomin), and Dysport units are calibrated independently — they are not interchangeable on a 1:1 basis with units of other botulinum toxin products.
Specifications
Common application zones
Application zones below are common indications for which botulinum toxin type A is used by practitioners. Specific dosing per zone is determined by the treating practitioner based on individual patient anatomy and clinical judgment.
Contraindications
Frequently asked questions
Dysport 500U is FDA-approved abobotulinumtoxinA manufactured by Ipsen Biopharm Ltd. Each single-use vial contains 500 Dysport-calibrated Speywood Units of botulinum toxin type A as vacuum-dried powder for reconstitution. The 500U pack is the standard format for Dysport in Korean wholesale channels.
Dysport is manufactured by Ipsen Biopharm Ltd. — a subsidiary of Ipsen, a French pharmaceutical company. Manufacturing facilities are located in France and the United Kingdom. Ipsen has produced abobotulinumtoxinA since the 1990s under the Dysport brand name (and Azzalure for some European cosmetic indications).
No. Dysport units are calibrated independently as Speywood Units and are NOT interchangeable on a 1:1 basis with units of Allergan Botox (onabotulinumtoxinA) or Xeomin (incobotulinumtoxinA). Published unit-conversion ratios vary by indication and treatment zone, but a commonly cited general ratio is approximately 2.5–3 Dysport units to 1 Botox/Xeomin unit. Practitioners must consult product-specific clinical literature before switching between products — mixing units 1:1 will result in significant over- or under-dosing.
Yes. This listing is the Korean-imported wholesale channel version with English labels and KFDA registration. The active ingredient abobotulinumtoxinA, manufacturing facility (Ipsen Biopharm in France/UK), and product specifications are identical to Dysport sold through other regional channels.
Dysport is vacuum-dried. Vacuum-drying produces a much thinner product layer than freeze-drying — the vial may appear nearly empty or have only a faint dried film. This is normal product appearance, not a defect. The full 500 Speywood Units of abobotulinumtoxinA are present and dissolve when reconstituted with sterile saline.
FDA-approved indications include cosmetic glabellar lines (since 2009), cervical dystonia, and upper and lower limb spasticity in adults and pediatric patients. Off-label aesthetic uses include forehead lines, lateral canthal lines, masseter contouring, and platysma bands. Specific dosing per zone is determined by the treating practitioner.
Both are FDA-approved botulinum toxin type A. Dysport contains abobotulinumtoxinA (manufactured by Ipsen in France/UK); Allergan Botox contains onabotulinumtoxinA (manufactured by Allergan in Westport, Ireland). Dysport has lighter molecular weight distribution and different complex protein profile. Critically, units are NOT 1:1 interchangeable. Dysport carries lactose; Allergan Botox does not.
Both are FDA-approved botulinum toxin type A. Dysport contains abobotulinumtoxinA (Ipsen); Xeomin contains incobotulinumtoxinA (Merz, Germany). Dysport includes complexing accessory proteins; Xeomin contains only the 150 kDa pure neurotoxin (Merz XTRACT proprietary purification). Dysport units are NOT 1:1 interchangeable with Xeomin units.
Dysport’s labeled shelf life is 24 months unopened (vs 36 months for Allergan Botox and Xeomin). This reflects Ipsen’s specific stability studies and is documented in Dysport’s official prescribing information. Reconstituted Dysport should be used within 4 hours per Ipsen labelling (vs 24 hours for many other botulinum toxin products).
Store unopened vials at 2–8 °C, protected from light. Do not freeze. After reconstitution with 0.9% sterile saline, use within 4 hours per Ipsen labelling. Discard any unused reconstituted product per institutional protocol.
Cassiopeia_Sun –
Absolutely love the packaging and the reliability of this vendor. Dysport kicks in so fast it almost catches you off guard. Took care of my crow’s feet and tech-neck lines effortlessly. It does feel a bit softer than Botox, which I prefer because I hate the heavy, heavy forehead feeling.
Joy –
This 500U vial is the best value for money if you do your masseters and forehead like I do. Compared to Xeomin, I feel Dysport lasts a solid month longer for me. It’s my third time ordering from this site, and the cold-chain shipping was spot on.
Marcus Reynolds –
Ordered 20 vials of Dysport 500U from fillersfairy for my clinic after comparing suppliers. Their bulk discount saved me nearly $150! The real-time order tracking showed every step – from UK warehouse dispatch to the temperature-controlled delivery. The package arrived with proper ice packs. For legit neurotoxins at fair prices, this is our go-to now.